| Dr Michael Victor Herman, MD | |
|
2800 Main St, Bridgeport, CT 06606-4201 | |
| (203) 576-5440 | |
| (203) 576-5022 |
| Full Name | Dr Michael Victor Herman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 2800 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851316491 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 033064 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Victor Herman, MD 2800 Main St, Bridgeport, CT 06606-4201 Ph: (203) 576-5832 | Dr Michael Victor Herman, MD 2800 Main St, Bridgeport, CT 06606-4201 Ph: (203) 576-5440 |
News Archive
In this post in the Guardian's "Response" column, Jenny Tonge, chair of the U.K. all-party parliamentary group on population, development and reproductive health, responds to a Guardian opinion piece published last month entitled "Welcome baby seven billion: we've room on Earth for you."
REGENERX BIOPHARMACEUTICALS, INC. announced today that it has completed and analyzed the safety data from its double-blind, placebo controlled Phase I clinical trial evaluating the systemic administration of RGN-352. The trial included testing of a single escalating intravenous dose of the drug candidate on forty healthy volunteers in Phase IA and, subsequently, over a fourteen-day treatment period on forty volunteers in Phase IB.
Last night, the House approved, 417-1, a Senate bill staving off a 21 percent cut in Medicare payments to doctors. Some lawmakers grumbled the bill doesn't go far enough.
Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.
Mandela Parkway, a four-lane boulevard enhanced by a median with trees and a curving footpath, stretches along a 24-block section of West Oakland. It's the fruit of a grassroots neighborhood campaign to block reconstruction of an elevated freeway leveled by the Loma Prieta earthquake in 1989 and reimagine the thoroughfare to replace it.
› Verified 5 days ago
Mitchell Andrew Fogel, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 900 Madison Ave, Suite 209, Bridgeport, CT 06606 Phone: 203-335-0195 Fax: 203-335-7293 | |
Christian Heineken, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3180 Main St, Suite 301, Bridgeport, CT 06606 Phone: 203-373-9100 Fax: 203-365-8492 | |
Pasquale Masone, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3180 Main St, Suite 301, Bridgeport, CT 06606 Phone: 203-373-9100 Fax: 203-365-8492 | |
Kevin B Panzer, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1381 Reservoir Ave., Bridgeport, CT 06606 Phone: 203-371-5197 | |
Ms. Lucia Plichtova, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 267 Grant Street, Bridgeport, CT 06610 Phone: 203-384-3792 | |
Hilda Daureen Kyotakoze, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4920 Main St Fl 2, Bridgeport, CT 06606 Phone: 203-371-2986 | |
Karen A Hutchinson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 226 Mill Hill Ave, 3rd Floor, Bridgeport, CT 06610 Phone: 203-384-3873 Fax: 203-384-3829 |